| Literature DB >> 25491415 |
Muhannad Abu-Remaileh1, Rami I Aqeilan2.
Abstract
The WW domain-containing oxidoreductase (WWOX) encodes a tumor suppressor that is frequently altered in cancer. WWOX binds several proteins and thus is postulated to be involved in a variety of cellular processes. Interestingly, Wwox-knockout mice develop normally in utero but succumb to hypoglycemia and other metabolic defects early in life resulting in their death by 3-4 weeks of age. Cumulative evidence has linked WWOX with cellular metabolism including steroid metabolism, high-density lipoprotein cholesterol (HDL-C) metabolism, bone metabolism and, more recently, glucose metabolism. In this review, we discuss these evolving functions for WWOX and how its deletion affects cellular metabolism and neoplastic progression.Entities:
Keywords: WW domain-containing oxidoreductase; aerobic glycolysis; hypoxia-inducible transcription factor 1; metabolism; tumor suppressor
Mesh:
Substances:
Year: 2014 PMID: 25491415 PMCID: PMC4935230 DOI: 10.1177/1535370214561956
Source DB: PubMed Journal: Exp Biol Med (Maywood) ISSN: 1535-3699